Verition Fund Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Verition Fund Management's NEO Position: Q2 2026 in Review
Verition Fund Management increased its NeoGenomics (NEO) stake by 355% in Q2 2026, buying an estimated $762K and bringing the position to 101,235 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #1255.
Verition Fund Management first reported a position in NEO in Q3 2014 and has held it in 14 quarters since. The position peaked at $1.98M in Q3 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Verition Fund Management held 101,235 shares of NeoGenomics worth $1.48M as of Q2 2026.
- Verition Fund Management bought 78,978 NeoGenomics shares in Q2 2026, an estimated $762K.
- NeoGenomics made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1255 holding.
- Verition Fund Management first reported a position in NeoGenomics in Q3 2014 and has held it in 14 quarters since.
- Verition Fund Management's NeoGenomics position peaked at $1.98M in Q3 2025.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.